The medical device patents are filed by companies to protect unauthorized use of their innovative products through patent infringement. Patent attorneys focus on drafting of medical device patents with thorough research to ensure that strong set of patent claims are presented to the patent office. Medical device patents usually disclose patent claims that cover methods and devices related to cardiac ailments like Arrhythmia and Atrial Fibrillation. Cardiovascular disorders are the primary reason for a large number of casualties in the world. In 2008, 30% of all universal casualties were associated with cardiovascular diseases. It is further estimated that by 2030, about 23mn individuals will perish from cardiovascular ailments yearly. These ailments are common in high-income communities and low-income states alike.
Arrhythmia is a cardiac situation where the electrical movement of the heart is unstable, quicker (tachycardia), or stagnant (bradycardia). Although multiple arrhythmias are not life-threatening, few can provoke a cardiac arrest and even immediate death. Atrial fibrillation is the most common cardiac arrhythmia. In Atrial Fibrillation, electrical conduction via the heart ventricles is erratic and messy. While Atrial Fibrillation can have no symptoms, it is frequently linked with pulses, shortness of breath, fainting, chest discomfort, or congestive heart failure. Atrial Fibrillation is similarly linked with atrial clot formation, which is attributed to clot migration and seizure. Atrial fibrillation is generally treated by obtaining an Electrocardiogram (ECG) of a patient, which indicates a specific Atrial Fibrillation waveform. To treat Atrial Fibrillation, a patient can take prescriptions to delay the heart rate or alter the momentum of the heart. Patients can similarly consume anticoagulants to deter atrial clot formation and stroke, and may even endure surgical intervention involving cardiac ablation to deal with atrial fibrillation.
Frequently, a patient with Arrhythmia or Atrial Fibrillation is overseen for prolonged periods to regulate the disease. Recent ambulatory electrocardiography tools like Holter monitors are bulky and tough for patients to supervise without the assistance of a medical expert. These conditions can hinder the actions of the patient like their natural activity, bathing, and showering. After an ECG is developed, the ECG is transmitted to the patient’s doctor who examines it and delivers a diagnosis and other suggestions. This is the general practice followed by patients who have to visit their doctors or hospitals regularly.
With the introduction of ECG devices to the consumers, the market has evolved drastically, and patents are usually granted for such medical device innovations. Generally, such patents disclose various unique features, like Cardiac Performance Monitoring Systems. In some interpretations, they can be referred to as SCG monitoring systems. These systems can incorporate control logic for regulating a mobile device, and for regulating the accelerometer of a mobile device so that it recognizes an SCG signal. A monitoring system can be designed to contain software for a mobile device that has the control logic to regulate the device to utilize its prevailing elements to evaluate, record, transmit, and examine a seismocardiogram.